GPhC reveals draft criteria to cut record number of fitness-to-practise concerns The General Pharmaceutical Council said that concerns raised have doubled over the past five years, from 2,989 in 2020/2021 to 6,202 in 2024/2025.…
GPhC chief executive to step down after 15 years in post Duncan Rudkin has served as chief executive of the General Pharmaceutical Council since the regulator was established in 2010.…
NPA warns of ‘spiralling demand’ for NHS weight-loss medications Survey results revealed that nearly one-quarter of UK adults tried to access weight-loss treatments in the past year via pharmacies.…
Regulator plans policy overhaul on disqualification powers The General Pharmaceutical Council said it will close disqualification cases against pharmacy owners that are no longer in the public interest and pose no risk to the public.…
MHRA approves first needle-free emergency treatment for anaphylaxis EURneffy, a single-dose nasal spray, is approved for the emergency treatment of anaphylaxis in patients weighing 30kg or more.…
GPhC confirms 6% fee rise following consultation The regulator said that the decision to raise its annual registration fees was influenced by increased operational costs and a need to ensure that it effectively carries out its regulatory responsibilities.…
Regulator to trial independent complaint handling service as fitness-to-practise reports reach ‘record high’ The General Pharmaceutical Council says that concerns reported to the regulator have increased by 13% year on year and by more than 100% over the past four years.…
GPhC highlights need to improve performance in five-year strategy To meet its goals under its strategic plan for 2025–2030, the regulator said it must improve its fitness-to-practise processes, streamline investigations and ensure financial stability.…
Recognising adverse events and using the Yellow Card system An overview of how to identify, manage and report adverse events.…
Funding gap: economic analysis paints dire picture of community pharmacy’s sustainability An independent economic analysis has revealed that the cost of delivering community pharmacy NHS services in England far outstrips the funding available, even after the uplift agreed in the latest contract negotiations.…
